Actively Recruiting
Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics: an Adaptation of the Memory Test With Self-Initiated Items (MAI)
Led by Centre Hospitalier de Lens · Updated on 2026-05-08
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to develop and assess an ecological tool called the Memory Test With Self-Initiated Items (MAI) to evaluate episodic memory in older adults aged 70 and above. Participants include those with and without neurocognitive disorders, such as Alzheimer's disease, mixed dementia, and other neurodegenerative conditions. The study seeks to compare memory performance between these two groups to better understand memory impairments in geriatrics. Participants undergo a neuropsychological assessment using the ecological MAI test to identify the presence or absence of neurodegenerative disease. They are divided into two groups: those with neurocognitive disorders and those without. The assessment lasts about 30 minutes for patients seen during routine care and up to 2 hours 30 minutes for accompanying persons or those recruited from external institutions like senior clubs. During the study, participants will be evaluated on overall memory performance and specific aspects of episodic memory, including temporal, spatial, and association components. Researchers will monitor participants for any fatigue during testing. No significant constraints are expected for those attending scheduled consultations. The study's duration and follow-up details are aligned with routine care and study visits. The main outcome is to compare ecological MAI scores between the two groups on the day of assessment.
CONDITIONS
Brief Title
Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 70 years or older
- Person able to move independently
- Person agrees to participate
- Group 1: Diagnosis of neurodegenerative disease with MMSE between 17 and 24
- Group 2: No neurodegenerative disease with MMSE 25 or higher
You will not qualify if you...
- Person under legal protective measures
- Person deprived of liberty
- Mental retardation or MMSE 16 or below
- Verbal understanding disorders
- Major visual disturbances
- Disease causing increased fatigue
- Psychiatric pathology except anxiety disorder or mild depression
- Person not covered by French national health insurance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day 1
Participants undergo neuropsychological assessment including the ecological MAI test to determine the presence or absence of neurodegenerative disease.
1 visit (in-person lasting 30 minutes to 2.5 hours depending on participant group)
Trial Site Locations
Total: 1 location
1
Centre Hospiralier de Lens
Lens, France, 62408
Actively Recruiting
Research Team
B
Brunhilde CANESSON
M
Mélanie VERLAY
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here